Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Int Urogynecol J. 2016 Feb 17;27(8):1215–1220. doi: 10.1007/s00192-016-2975-y

Table 3.

Risk of voiding trial failure by predictor

Predictor Passed voiding trial
N = 245
Failed voiding trial
N = 49
P value Crude RR
(95 % CI)
Adjusted RR
(95 % CI)a
Preoperative PVR 0.001
  <150 221 (86.0) 36 (14.0) Ref Ref
  ≥150 24 (64/9) 13 (35.1) 2.5 (1.5–4.3) 1.9 (1.1–3.2)
Institution <0.0001
  BIDMC 82 (70.7) 34 (29.3) 3.5 (2.0–6.1) 3.0 (1.6–5.4)
  MAH 162 (91.5) 15 (8.5) Ref Ref
Race 0.04
  Black 8 (61.5) 5 (38.5) 2.7 (1.3–5.7) 1.5 (0.80–2.9)
  Hispanic 11 (73.3) 4 (26.7) 1.9 (0.8–4.5) 1.1 (0.41–2.7)
  Other 11 (73.3) 4 (26.7) 1.9 (0.8–4.5) 1.5 (0.61–3.9)
  White 215 (85.7) 36 (14.3) Ref Ref

Data presented as n (%)

BIDMC Beth Israel Deaconess Medical Center, MAH Mount Auburn Hospital, RR risk ratio, CI confidence interval

a

Models adjusted for other variables in the table